Insights On Enterprise Solutions

  1. Why The CRO–Sponsor Relationship Is Becoming A Strategic Advantage 10/5/2026

    Shared real-time data environments transform CRO-sponsor relationships, replacing communication silos with transparent, audit-ready clinical bioanalysis.

  2. Protective Shell For 2D Bags: Engineered For Mechanical Protection 10/2/2026

    Protect frozen single-use bag assemblies from movement and handling stress with rigid secondary packaging, dedicated foam immobilization, and efficient plate-freezing heat transfer.

  3. CMC Considerations Around Unique Materials And Reagents 10/2/2026

    In this segment from the Bioprocess Online Live event, “Making The Jump To GMP: Material Decisions For Clinical Manufacturing,” panelists advise on what to do when no GMP-grade equivalents exist for certain starting materials or reagents.

  4. The CDMO's Perspective: Audience Q&A With Thermo Fisher Scientific 10/2/2026

    During this final segment from the Bioprocess Online Live event, “Making The Jump To GMP: Material Decisions For Clinical Manufacturing,” a representative and SME from the event sponsor enters the conversation. Mike Brewer, director and global principal consultant of regulatory and bioproduction at Thermo Fisher Scientific, joins the panel for a special Q&A session with the audience, discussing the challenges he’s witnessed sponsor companies face in the transition to clinical manufacturing.

  5. Transitioning A Process And Qualifying GMP Materials 10/2/2026

    This opening segment from the Bioprocess Online Live event, “Making The Jump To GMP: Material Decisions For Clinical Manufacturing,” features panelists Tiffany Rau, Ph.D., an adjunct professor at University College Cork, co-founder of BioPharam Technical Consulting, and founder of Rau Consulting; Mary Rodley, an independent consultant at Medius Consulting; and Wei Lu, Ph.D., a senior staff engineer in downstream process development at Takeda. They share their thoughts on when preparation for clinical manufacturing should begin, especially in terms of qualifying compendial and GMP-grade materials.

  6. Demonstrating Process Fit With A Single-Use TFF System 10/2/2026

    A facility-fit constraint challenged the transfer of an ultrafiltration process to a new site. Learn how engineers increased membrane loading by 50% while maintaining performance.

  7. Data-Centric Organoid Services For Predictive Drug Response And Next-Generation Oncology Research 10/1/2026

    Patient-derived organoids are gaining traction as translational tools in oncology, but their value depends on the quality and context of the data they generate, not the models alone.

  8. Product Carbon Footprint: Enabling Product-Level Decarbonization In Biopharma 10/1/2026

    Facility-level and spend-based carbon accounting leave critical gaps in biopharma Scope 3 management. This whitepaper examines how batch-level product carbon footprinting changes what's measurable and what's actionable.

  9. Bridging Discovery, Developability, And Commercial Reality 9/29/2026

    Driven by metabolic and oncology successes, the expanding peptide therapeutics market faces critical challenges requiring early, customized drug product development, stability, and safety strategies.

  10. Enabling Closed-System Bioprocessing With Single-Use Technologies 9/28/2026

    Learn how custom single-use solutions create closed fluid pathways across upstream and downstream operations, helping manufacturers strengthen sterility assurance and simplify scale-up.